Abstract
Analytical microchips can be considered one of the fastest growing technology
segments in life sciences. The range of applications to which these miniature
laboratories may be directed is very broad - covering fields as different as
pharmaceutical development, food testing, clinical diagnostics, forensics, and
environmental analysis.
Kalorama' s Analytical Chip Technology: U.S. Markets for Lab on a Chip,
DNA/Gene, Protein and other Microarrasys) 3rd. Edition of its report on this
exciting marketplace analyzies the world market for analytical microchips with
a unique methodology -- the market is expressed in terms of its potential as
opposed to experienced and projected revenues. As the author Ken Krul states,
"The status of the current market in terms of revenues is misleading of the
potential market as a whole. It does not allow for the understanding of the
potential of unmet need. The difference can be as stark as the difference
between the surface of the sun and the dark side of the moon."
This is a particular important point in a growing research-based market such
as analytical chips. In this report, Krul' s unique analysis is based on:
- The current and expected levels of genomic and proteomic research;
- The general trends in technological development for genomics and
proteomics, and other factors that affect those trends;
- The trends in pharmaceutical research and development, both in terms of
technology and the need for high-throughput approaches and equipment; and
- Costs of analysis based on studies of actual research and projected costs
of new technologies by those engaged in their development.
The report breaks up microchip usage into the following segments and forecasts
to 2017:
- DNA/Genetics
- Protein
- Cell
- Tissue
- Microbiology
- Process ("Lab on a Chip")
The analysis presented in this report is based on data from a combination of
company, government, industrial, institutional and private sources. It
includes information from extensive literature reviews, as well as interviews
and discussions with experts in the field, including experts in genomics and
proteomics, pathologists, research scientists, and business development and
marketing managers.
Table of Contents
CHAPTER ONE: Executive Summary
- Background
- Scope and Methodology
- Size and Growth of Market
- Analytical Microchips Market
- Analytical Chips for DNA/Gene Microarrays
- Analytical Chips for Protein Microarrays
- Analytical Chips for Microbiology Microarrays
- Analytical Chips for Tissue Microarrays
- Analytical Chips for Cell Microarrays
- Analytical Process Microchips
- Key Occurances in the Analytical Chip Market
CHAPTER TWO: Introduction
- Background
- Early Analytical Chip Products
- New Chip Applications
CHAPTER THREE: DNA/Gene and
- Microbiology Microarrays
- DNA/Gene Microarrays
- DNA/Gene Microarray Production
- Gene and Clone Selection
- DNA/Gene Microarray Applications
- Genotyping
- Gene Expression Measurement
- DNA/Gene Microarray Informatics
- Microbiology Arrays
- Microbiology Array Technology
- Microbiology Microarray Applications
- Drug/Vaccine Discovery and Development
- Microbiology Microarray Commercialization
CHAPTER FOUR: Protein Microarrays
- Background
- Protein Array Applications
- Drug Discovery and Development
- Clinical Diagnostics
- Protein Microarray Commercialization
CHAPTER FIVE: Cell and Tissue Microarray
- Cell Microarray Technology
- Cell Microarray Applications
- Transcriptional Regulation
- Drug Discovery and Development
- Cell Microarray Commercialization
- Tissue Microarrays
- Tissue Microarray Technology
- Tissue Microarray Commercialization
CHAPTER SIX: Process Microchips: Lab-On-A-Chip Technology
- Overview
- Microchip Technology
- LOC Applications
CHAPTER SEVEN: Company Profiles
- Overview
- Accelr8 Technology Corporation
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Ambion, Inc.
- Bio-Rad Laboratories
- Caliper Life Sciences
- Invitrogen Corporation
- Nanogen, Inc.
- NimbleGen Systems, Inc.
- TeleChem International, Inc.
CHAPTER EIGHT: Market Analysis
- DNA/Gene Microarrays
- Protein Microarrays
- Cell Microarrays
- Tissue Microarrays
- Microbiology Microarrays
CHAPTER NINE: Conclusions and Strategic Implications
- First Conclusion
- Second Conclusion
- Third Conclusion
- Fourth Conclusion
- Fifth Conclusion
- Sixth Conclusion
- Seventh Conclusion
- Eighth Conclusion
- Ninth Conclusion
APPENDIX
table of exhibits
- Executive Summary
- Figure 1-1: The Market Potential for Analytical Microchips in the United
States: 2007 - 2017
- Table 1-1 : Estimated Market Potential for United States Market for
Analytic Microchips: 2007 - 2017 by Application (DNA/Gene, Protein, Cell,
Tissue, Microbiology, Process)
- Figure 1-2 : Growth in the United States Market Potential for DNA/Gene
Microarray Products: 2007 - 2017
- Figure 1-3 : Growth in the United States Market for Protein Microarray
Products: 2007 - 2017
- Figure 1-4 : Growth in the United States Market for Microbiological
Microarray Products: 2007 - 2017
- Figure 1-5: Growth in the United States Market for Tissue Microarray
Products: 2007 - 2017
- Figure 1-6 : Growth in the United States Market for Cell Microarray
Products: 2007 - 2017
- Figure 1-7 : Growth in the United States Market for Process Microchip
Products: 2007 - 2017
CHAPTER THREE: DNA/Gene and Microbiology Microarrays
- Table 3-1:Selected Genomics Databases
CHAPTER FOUR: Protein Microarrays
- Table 4-1: Key Competitors in Antibody and Protein Microarray Technology
- Cell and Tissue Microarray
- Table 5-1: Key Competitors in Cell and Tissue Microarray Technology
- Process Microchips: Lab-On-A-Chip Technology
- Table 6-1: Advantages and Disadvantages of LOC Technology
- Table 6-2: Key Competitors in Cell Process Microchip (LOC) Technology
- Market Analysis
- Table 8-1: Historic and Projected United States Market Potential for
Analytical Microarrays: 2007-2017
- Table 8-2 Historic and Projected United States Market Potential for
DNA/Gene Microarrays: 2007-2017
- Figure 8-2 Trends in the Historic and Projected United States Market
Potential for DNA/Gene Microarrays: 2007-2017
- Table 8-3 Historic and Projected United States Market Potential for
Protein Microarrays: 2007-2017
- Figure 8-3: Trends in the Historic and Projected United States Market
Potential for Protein Microarrays: 2007-2017
- Table 8-4: Historic and Projected United States Market Potential for Cell
Microarrays: 2007-2017
- Figure 8-4: Trends in the Historic and Projected United States Market
Potential for Cell Microarrays: 2007-2017
- Table 8-5: Historic and Projected United States Market Potential for
Tissue Microarrays: 2007-2017
- Figure 8-5 Trends in the Historic and Projected United States Market
Potential for Tissue Microarrays: 2007-2017
- Table 8-6: Historic and Projected United States Market Potential for
Microbiology Microarrays: 2007-2017
- Figure 8-6: Trends in the Historic and Projected United States Market
Potential for Microbiology Microarrays: 2007-2017
- Table 8-7: Historic and Projected United States Market Potential for
Process Microchips: 2007-2017
- Figure 8-7: Trends in the Historic and Projected United States Market
Potential for Process Microchips: 2007-2017 229
|
